Virtu Financial LLC Natera, Inc. Transaction History

Virtu Financial LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$85.28 - $112.6 $132,354 - $174,755	1,552 Added 20.06%	9,288 $1.01 Million
Q1 2024 May 20, 2024	BUY	$59.21 - $92.9 $458,048 - $718,674	7,736 New	7,736 $707,000
Q3 2023 Nov 14, 2023	BUY	$43.4 - $62.52 $384,741 - $554,239	8,865 New	8,865 $392,000
Q1 2023 May 01, 2023	BUY	$36.57 - $58.29 $501,740 - $799,738	13,720 New	13,720 $762,000
Q2 2022 Aug 09, 2022	BUY	$28.13 - $44.54 $278,683 - $441,257	9,907 New	9,907 $351,000
Q1 2021 May 19, 2021	SELL	$91.47 - $124.36 $706,331 - $960,307	-7,722 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$66.66 - $111.74 $514,748 - $862,856	7,722 New	7,722 $768,000
Q2 2020 Aug 07, 2020	SELL	$26.36 - $49.86 $235,447 - $445,349	-8,932 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$32.1 - $40.4 $286,717 - $360,852	8,932 New	8,932 $301,000
Q3 2019 Nov 20, 2019	SELL	$25.38 - $34.89 $272,048 - $373,985	-10,719 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$17.75 - $27.58 $190,262 - $295,630	10,719 New	10,719 $296,000
Q2 2018 Jul 30, 2018	SELL	$8.79 - $19.98 $143,980 - $327,272	-16,380 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$8.79 - $19.98 $143,980 - $327,272	16,380 New	16,380 $308,000

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.